Thu, Apr 17, 2014, 12:32 PM EDT - U.S. Markets close in 3 hrs 28 mins


% | $
Quotes you view appear here for quick access.

Array BioPharma, Inc. Message Board

  • dcaf7 dcaf7 Feb 4, 2013 5:41 PM Flag

    New selumetinib phase 1 study just started

    Study of Selumetinib in Patients With Previously Treated or Untreated Advanced/Metastatic NSCLC.
    This research is being done because further research on selumetinib in combination with standard chemotherapy treatment is needed.
    Three arms of the study include treatment with
    a) paclitaxel and carboplain plus selumetinib
    b) pemetrexed and cisplain plus selumetinib
    c) pemetrexed plus selumetinib

3.75-0.09(-2.34%)12:32 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.